financetom
Business
financetom
/
Business
/
Here's what experts have to say on IDBI Bank stake sale to LIC
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Here's what experts have to say on IDBI Bank stake sale to LIC
Jun 22, 2018 2:04 PM

A quarter of its loan book gone bad, a net loss of over Rs 5,600 crore in just the Q4, a halt in corporate lending and a shrinkage in international operations.

IDBI Bank clearly finds itself in choppy waters and the government finds itself desperately looking for a solution.

Reports coming in today indicate that the government is considering selling a significant stake in IDBI Bank to Life Insurance Corporation (LIC).

But sources tell CNBC-TV18 that while discussions are on, no proposal has been taken to the LIC board yet. A proposal once finalised will first have to be cleared by LIC's investment & strategy committee and the quantum of stake to be bought will depend on negotiations & decision by the committee.

Speaking to CNBC-TV18, BP Sharma, former executive director at Bank of India, said that news is speculative and definitely government is keen to reduce stake in IDBI Bank, which is not coming strictly a public sector bank.

Sharma said privatisation of the bank is not feasible in the near future and that is why government is trying to reduce stake and there is nothing wrong in that.

AK Bhattacharya, Editorial Director at Business Standard, blames government for not privatising IDBI Bank.

Government is trying to shore up its disinvestment revenues through this and around Rs 10,000-11,000 crore is likely to be garnered through this sale, Sharma said to CNBC-TV18.

Bhattacharya said, "LIC need to be very sure that their investment needs to safe, sound and prudent. I see this attempt as using regulatory forbearance to get the country’s largest insurer to have a stake in the bank."

He further added, “I hope Insurance Regulatory and Development Authority (IRDA) takes necessary note of this and it's not a good sign."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Medical Properties Trust Prioritizes California Investments in Prospect Medical Group Chapter 11
Medical Properties Trust Prioritizes California Investments in Prospect Medical Group Chapter 11
Jan 13, 2025
05:01 AM EST, 01/13/2025 (MT Newswires) -- Medical Properties Trust ( MPW ) said Sunday that it is prioritizing the protection of its investments in Prospect Medical Group's California hospitals as Prospect commences Chapter 11 bankruptcy restructuring. While Prospect's California facilities have reported volume growth and improved coverage trends in 2024, its overall liquidity has been adversely impacted by stalled...
Lilly sues two medical spas over copycat weight-loss drugs
Lilly sues two medical spas over copycat weight-loss drugs
Jan 13, 2025
Jan 13 (Reuters) - Eli Lilly ( LLY ) said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound. The new lawsuits name Thrive Health and Wellness LLC and Valhalla Vitality LLC. Lilly said the companies were selling unapproved drugs and making false claims...
Biden admin delays enforcement of order blocking Nippon Steel, US Steel deal, companies say
Biden admin delays enforcement of order blocking Nippon Steel, US Steel deal, companies say
Jan 13, 2025
WASHINGTON (Reuters) -The Biden administration delayed until June an order for Nippon Steel to abandon its $14.9 billion bid for U.S. Steel, the companies said on Saturday, giving them some time to revive the politically contentious deal. President Joe Biden blocked the acquisition on national security grounds on Jan. 3, and Treasury Secretary Janet Yellen said this week the proposed...
Molecular Partners Expands Clinical Collaboration With Orano Med to Add 6 Targeted Alpha Radio-Therapies for Cancer
Molecular Partners Expands Clinical Collaboration With Orano Med to Add 6 Targeted Alpha Radio-Therapies for Cancer
Jan 13, 2025
05:26 AM EST, 01/13/2025 (MT Newswires) -- Molecular Partners AG ( MOLN ) expanded its strategic collaboration with Orano Med to include the development of an additional six targeted alpha radio-therapies for cancer, the companies said Sunday. The companies entered into an initial agreement in January 2024 to co-develop four programs. Under the expanded collaboration, Molecular Partners ( MOLN )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved